Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Kericho Clinical Research Center (KCRC) is a premier clinical trial site located in Kericho, Kenya, operating as a collaboration between the Kenya Medical Research Institute (KEMRI) and the U.S. Army Medical Research Directorate-Africa (USAMRD-A). Established to address infectious disease threats, the center specializes in high-quality clinical research, particularly for HIV, malaria, and tuberculosis vaccines and therapeutics. KCRC features state-of-the-art laboratories and clinical facilities that meet international standards for Good Clinical Practice (GCP). The center plays a vital role in global health by conducting Phase 1 through Phase 3 clinical trials and providing comprehensive care to the local community. Its work is instrumental in the development of life-saving interventions for diseases prevalent in sub-Saharan Africa. The facility also serves as a critical hub for scientific training and capacity building in the East African region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kericho Clinical Research Center.